When a healthcare IT company faces a $57 million federal settlement, employee layoffs, and a visible shift away from legacy products, it’s natural to wonder whether the lights are about to go out. For clinics and practices running on Greenway Health’s software, that concern is more than academic — it touches patient records, billing workflows, and daily operations.
So let’s look at what the evidence actually shows, separate the real warning signs from the noise, and help current or prospective clients think clearly about their risk.
What Greenway Health Is and Where It Stands Today
Greenway Health is a privately held US company based in Tampa, Florida, with additional offices in Bangalore, India. It builds EHR (electronic health record), practice management, and revenue cycle management software for ambulatory medical practices — think independent clinics, specialty practices, and physician groups rather than large hospital systems.
Its main products include Intergy, PrimeSUITE, and a newer platform called Novare. As of the latest available information, Greenway is still operating. Its website is active, it continues marketing products, and there has been no public announcement of bankruptcy, closure, or wind-down from any credible source.
The company is privately held, which matters for one key reason: it doesn’t file public financial disclosures. That opacity can make the company feel harder to read, and that uncertainty sometimes fuels speculation about its health.
The Corporate History Behind the Ownership Questions
Greenway’s roots trace back to Medical Manager in the 1980s — one of the earliest practice management software systems in the US. Over the following decades, a series of acquisitions and mergers gradually shaped what the company is today.
The most significant recent turning point came in 2013, when Vista Equity Partners, a private equity firm, acquired Greenway Medical Technologies and took it private. Greenway Medical was then combined with Vitera Healthcare Solutions to form the current entity, Greenway Health.
Private equity ownership doesn’t automatically signal instability. What it does change is the visibility of financial data. PE-owned companies don’t trade on public markets, don’t publish quarterly earnings, and aren’t required to disclose most financial details. For outsiders trying to assess stability, that can feel unsettling — but the absence of public data is not the same as a sign of trouble.
The $57 Million DOJ Settlement and What It Did — and Did Not — Mean
This is the event that did the most damage to Greenway’s reputation, and it’s worth understanding clearly. In 2019, Greenway agreed to pay $57.25 million to resolve allegations brought by the US Department of Justice under the False Claims Act.
The allegations centered on two issues: that Greenway misrepresented certain capabilities of its PrimeSUITE EHR when seeking federal certification, and that it provided what the government characterized as unlawful remuneration to users. As part of the resolution, Greenway entered into a five-year Corporate Integrity Agreement with the HHS Office of Inspector General, which required the company to implement compliance changes, submit to monitoring, and meet ongoing reporting obligations.
That’s a serious consequence — both financially and reputationally. But the settlement did not result in the company closing. Greenway continued operating under stricter compliance requirements, and it wasn’t alone in facing this kind of scrutiny. Several other EHR vendors have faced similar federal actions related to certification practices and incentive structures. This was an industry-wide pattern, not a Greenway-specific collapse.
The Corporate Integrity Agreement, while it sounds alarming, actually represents a structured path forward under government oversight — not a shutdown order.
Layoffs, Restructuring, and Why Neither Equals Closure
Employee reviews on Glassdoor and discussions on Reddit have, at various points, referenced layoffs and internal reorganizations at Greenway. Some posts have alleged that hundreds of employees were let go during specific periods. These accounts deserve acknowledgment — they describe real disruption for the people involved.
But it’s worth being precise about what layoffs actually indicate. They are common across the healthcare IT sector, particularly during product transitions, cost restructuring, or changes in private equity strategy. A company can reduce its headcount significantly and still remain fully operational for its clients.
The signals that would actually suggest a company is failing look different:
- Formal bankruptcy filings with the courts
- Abrupt shutdowns of products or support lines
- Failure to meet regulatory certification deadlines
- Credible reporting from major business press about loan defaults or imminent closure
None of those signals are present in credible sources as of the latest available information. Layoffs and restructurings, while concerning for employees, are not the same thing as a company going out of business.
What Greenway Is Actually Doing Right Now
The clearest counterevidence to the “going out of business” narrative is Greenway’s current activity level. The company is actively marketing AI-enabled EHR solutions, practice management tools, and revenue cycle management services on its website. Its product pages are updated, and client-facing content is current.
More notably, Greenway has invested in building a new platform from the ground up. Novare is described as a reimagined EHR designed to fix what its Chief Medical Officer, Michael Blackman, has publicly called “broken” and fragmented traditional EHR workflows. Rather than layering AI features onto existing systems, the stated goal with Novare is to rebuild the entire workflow and clinical decision support structure with AI integrated from the start.
Blackman has discussed this strategy publicly, including at HIMSS — one of the largest healthcare IT conferences in the industry. Companies that are quietly winding down don’t typically present new platforms at major industry conferences or invest in rebuilding their core product.
That level of investment points to strategic repositioning, not exit planning.
Customer Complaints: Real Issues, But Not Proof of Collapse
It’s fair to note that Greenway has accumulated complaints on the Better Business Bureau and other platforms. These touch on billing service failures, support responsiveness, and disputes over contract terms. Some customers have clearly had difficult experiences.
Service problems and business failure are two different things, though. A company can have real performance issues and still remain operational. What complaints do signal is that clients should pay attention to SLA terms, support responsiveness, and what their contracts say about data access — not that Greenway is days away from shutting down.
How to Think About Vendor Risk Without Overreacting
Whether you’re a current Greenway client or evaluating the platform for the first time, the right approach isn’t panic — it’s preparation. Every mid-sized private EHR vendor carries some level of uncertainty. The practical question is whether your practice is protected if circumstances change.
A few things worth checking if you’re a current Greenway user:
- Data export rights: Review what your contract says about exporting patient data in standard formats (CCD, FHIR). This matters regardless of which vendor you use.
- Product roadmap clarity: Ask Greenway directly about the long-term support plan for Intergy and PrimeSUITE versus the migration path to Novare. Understanding the timeline helps you plan.
- Termination clauses: Know what your exit options look like and what notice period applies if you decide to switch vendors.
- Business continuity language: Some contracts include provisions that address what happens to data and service access in the event of an acquisition or operational change.
For practices considering Greenway as a new vendor, the same due diligence applies here as with any private EHR company: check references from current clients, review the product roadmap, and make sure the contract offers reasonable protections.
For broader context on evaluating business risk in healthcare IT and other industries, BusinessBase covers vendor strategy and market analysis that may be useful.
The Bottom Line
Based on available evidence, Greenway Health is not going out of business. The company is actively operating, marketing products, developing a new platform, and maintaining a public presence in the industry. The $57 million DOJ settlement was a significant and costly event, but it occurred in 2019 and did not end the company. Layoffs and restructurings have happened, as they have across most of the healthcare IT sector, but they are not the same as closure.
What’s true is that Greenway is a privately held company in a competitive, fast-moving market, operating under the legacy of a serious federal compliance case and in the middle of a significant product transition. That combination is worth paying attention to — not because collapse is imminent, but because any medical practice that depends on a single vendor should understand its options.
The smartest position isn’t worry. It’s knowing exactly what your contract says and having a reasonable contingency plan in place.
Read Also:
